|
市場調査レポート
商品コード
1384902
美容医療の世界市場規模、シェア&産業動向分析レポート:エンドユーザー別、施術別、製品別、地域別展望と予測、2023年~2030年Global Medical Aesthetics Market Size, Share & Industry Trends Analysis Report By End User (Clinics, Hospitals, & Medicals Spas, Beauty Centres, & Home Care Settings), By Procedure, By Product, By Regional Outlook and Forecast, 2023 - 2030 |
||||||
|
美容医療の世界市場規模、シェア&産業動向分析レポート:エンドユーザー別、施術別、製品別、地域別展望と予測、2023年~2030年 |
出版日: 2023年10月31日
発行: KBV Research
ページ情報: 英文 400 Pages
納期: 即納可能
![]() |
美容医療市場規模は2030年までに311億米ドルに達すると予測され、予測期間中のCAGRは10.4%の市場成長率で上昇する見込みです。
KBV Cardinalのマトリックスに示された分析によると、Allergan PLCとJohnson &Johnsonが同市場の先行者です。2021年12月、Allergan PLCはSoliton, Incを買収し、セルライトの見た目に対処する実証済みの方法を導入することで、Allergan Aestheticsの非侵襲的身体彫刻ソリューションの範囲を強化しました。Galderma S.A.、Merz Pharma GmbH &Co.KGaA、Alma Lasers Ltd.などの企業が、この市場における主要なイノベーターです。
COVID-19影響分析
パンデミックの初期段階では、多くの美容クリニックや医療スパが、ロックダウンや社会的距離の確保、ウイルス感染への懸念のために、一時的な閉鎖や営業制限を余儀なくされました。このため、エステティック・プロバイダーにとっては、患者の来院数が減少し、収入も減少しました。パンデミック(世界的大流行)が拡大するにつれて、多くの人々が優先順位を選択的な美容施術から健康や安全への関心へとシフトさせました。また、経済の先行き不透明感から、一部の患者は美容医療への支出に慎重になっています。COVID-19の影響は市場に大きな影響を与えています。
市場成長要因
高齢化人口の割合の増加
世界人口の高齢化により、美容医療施術の需要が増加しています。加齢に伴う小じわ、しわ、皮膚のたるみに対処するため、アンチエイジング治療が頻繁に行われています。医療&美容施術を求める患者層は、40代、50代、そしてそれ以上の年齢層と、若々しい外見を維持するための予防的治療や早期介入治療に関心のある若年層へと拡大しています。したがって、長寿化が進み、個人が外見と健康を優先するようになるにつれて、高齢化社会の市場への影響は持続すると予想されます。
低侵襲・非外科的治療への需要の高まり
低侵襲・非外科的処置は、一般的に従来の外科的介入よりも回復期間が短いです。これらの治療により、患者は日常生活をより早く再開することができ、多忙なスケジュールを抱える人々にとって魅力的なものとなります。低侵襲手術は一般的に、手術に比べて合併症のリスクが低いです。患者は有害事象の可能性が低い治療に惹かれます。低侵襲・非外科的治療の人気の高まりが、美容医療市場の拡大につながっています。
市場抑制要因
厳しい規制遵守と安全基準
厳しい規制は、新規参入を困難にする可能性があります。必要な規制要件を満たし、承認を得るには時間とコストがかかります。安全性と有効性の基準を満たすために新しい美容製品や治療法を開発しテストすることは、コストがかかる可能性があります。メーカーは研究開発に多大な資源を投入する必要があるかもしれないです。市場における厳しい規制遵守と安全基準は課題です。
エンドユーザーの展望
エンドユーザー別に見ると、市場はクリニック、病院、医療スパ、美容センター、ホームケアに分けられます。2022年には、診療所、病院、医療スパ部門が最大の売上シェアで市場を独占しました。クリニックは、患者が形成外科医、皮膚科医、看護師などのヘルスケアプロバイダーと相談や評価を行うための安全で専門的な環境を提供します。これらのセッションで、患者は美容上の目標や懸念について話し合い、医療提供者は様々な治療に対する適性を評価します。病院には高度な医療設備、リソース、さまざまな専門医がいます。
施術の展望
美容医療ティック市場は、施術の内容によって外科的施術と非外科的施術に分類されます。外科的処置は、2022年の美容医療市場においてかなりの収益シェアを獲得しました。美容医療市場における外科手術は、傷跡を最小限に抑え、回復時間を短縮し、自然な仕上がりを実現することに重点を置き、技術やテクノロジーの進歩とともに進化し続けています。患者の安全性、専門医資格を持つ外科医、十分な情報を得た上での意思決定は、美容医療の外科的側面において不可欠な要素です。
外科手術の展望
外科手術の種類では、市場は豊胸術、フェイスリフト&ボディリフト、鼻形成術、その他に分類されます。2022年には、豊胸手術セグメントが市場で最大の収益シェアを記録しました。豊胸手術は、医療&美容市場で最も人気のある外科手術の1つです。多くの人が、バストの大きさや形を整え、体全体のプロポーションを改善し、自信を高めるために豊胸手術を受ける。様々な年齢や背景の女性が豊胸術を検討しており、幅広い患者にアピールする手術です。
製品の展望
製品別では、フェイシャルエステ製品、コスメティックインプラント、スキンエステティックデバイス、ボディコントゥアリングデバイス、医師が処方するコスメシューティカル&スキンライトナー、脱毛デバイス、タトゥー除去デバイス、その他に分類されます。化粧品インプラント分野は、2022年の市場でかなりの収益シェアを占めました。美容インプラントは、医療&美容市場において長年にわたり重要な構成要素となっています。様々な顔の特徴や体の輪郭を強調し、形を変えるために使用され、長期的な結果をもたらすことができます。最もよく知られている美容整形手術の1つは、シリコンまたは生理食塩水の豊胸インプラントによる乳房の増大です。
地域別展望
地域別に見ると、美容医療市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、北米地域が最も高い収益シェアを獲得し、美容医療市場をリードしました。北米では非外科的治療が特に人気です。一般的な施術には、ボトックスや皮膚フィラー注射、レーザー治療、ケミカルピーリング、マイクロダーマブレーションなどがあります。北米では人口の高齢化が進んでおり、老化の兆候に対処し、若々しい外見を維持するための治療を求める人が増えているため、医療&美容市場の拡大に寄与しています。
The Global Medical Aesthetics Market size is expected to reach $31.1 billion by 2030, rising at a market growth of 10.4% CAGR during the forecast period.
Skin aesthetic devices offer various treatment options, making them suitable for addressing skin concerns. This includes treatments for wrinkles, fine lines, acne scars, pigmentation issues, vascular conditions, and skin laxity. Therefore, the Skin Aesthetic Devices segment will capture approximately 10% share in the market by 2030. Many skins aesthetic devices are non-invasive or minimally invasive, reducing patient downtime and discomfort compared to surgical procedures. This appeals to a broad patient demographic, including those hesitant about surgery. Advancements in technology have led to skin aesthetic devices with high efficacy and safety profiles. When trained professionals use these devices, patients can achieve noticeable results with minimal risk of adverse effects.
The major strategies followed by the market participants are Acquisitions as the key developmental strategy to keep pace with the changing demands of end users. For instance, In December, 2022, Johnson & Johnson acquired Abiomed, to broaden its offerings in the rapidly growing cardiovascular sector by incorporating heart recovery solutions into our globally leading Biosense Webster electrophysiology business. In January, 2022, Galderma S.A. took over ALASTIN Skincare, to develop products that complement company's high-quality product lineup.
Based on the Analysis presented in the KBV Cardinal matrix; Allergan PLC and Johnson & Johnson are the forerunners in the Market. In December, 2021, Allergan PLC took over Soliton, Inc, to enhance Allergan Aesthetics' range of non-invasive body sculpting solutions by introducing a proven method for addressing the appearance of cellulite. Companies such as Galderma S.A., Merz Pharma GmbH & Co. KGaA, Alma Lasers Ltd., are some of the key innovators in the Market.
COVID-19 Impact Analysis
During the initial phases of the pandemic, many aesthetic clinics and medical spas had to temporarily close or limit their operations due to lockdowns, social distancing measures, and concerns about virus transmission. This led to a decline in patient visits and revenue for aesthetic providers. As the pandemic unfolded, many individuals shifted their priorities away from elective cosmetic procedures toward health and safety concerns. The economic uncertainty also made some patients more cautious about discretionary spending on aesthetic treatments. The COVID-19 impact has a significant impact on the market.
Market Growth Factors
Growing Proportion of Aging Population
An aging global population has led to increased demand for medical aesthetics procedures. Individuals frequently pursue anti-aging treatments to combat fine lines, wrinkles, and sagging skin as they age. The demographic of patients seeking medical aesthetics procedures has expanded to include those in their 40s, 50s, and beyond and younger individuals interested in preventative and early intervention treatments to maintain a youthful appearance. Therefore, the aging population's influence on the market is expected to persist as longevity increases and individuals prioritize their appearance and well-being.
Increasing Demand for Minimally Invasive and Non-Surgical Treatments
Minimally invasive and non-surgical procedures typically have shorter recovery periods than traditional surgical interventions. These treatments allow patients to resume their daily activities more rapidly, making them appealing to individuals with hectic schedules. Minimally invasive procedures generally carry a lower risk of complications compared to surgery. Patients are drawn to treatments with a lower likelihood of adverse events. The growing popularity of minimally invasive and non-surgical treatments has led to an expanding market for medical aesthetics.
Market Restraining Factors
Stringent Regulatory Compliance and Safety Standards
Stringent regulations can make it difficult for new players to enter the market. Meeting the necessary regulatory requirements and obtaining approvals can be time-consuming and expensive. Developing and testing new aesthetic products and treatments to meet safety and efficacy standards can be costly. Manufacturers may need to invest significant resources in research and development. Stringent regulatory compliance and safety standards in the market present challenges.
End User Outlook
On the basis of end user, the market is divided into clinics, hospitals, & medicals spas, beauty centres, and home care settings. In 2022, the clinics, hospitals, and medicals spas segment dominated the market with maximum revenue share. Clinics provide a safe and professional environment for patients to meet with healthcare providers, such as plastic surgeons, dermatologists, or nurse practitioners, for consultations and assessments. During these sessions, patients discuss their aesthetic goals and concerns, and healthcare providers evaluate their suitability for various treatments. Hospitals have advanced medical facilities, resources, and various medical specialists.
Procedure Outlook
Based on procedure, the medical aesthetics market is classified into surgical procedures and non-surgical procedures. The surgical procedures acquired a substantial revenue share in the medical aesthetics market in 2022. Surgical procedures in the medical aesthetics market continue to evolve with advancements in techniques and technology, focusing on achieving natural-looking results with minimized scarring and shorter recovery times. Patient safety, board-certified surgeons, and informed decision-making are essential components of the surgical aspect of medical aesthetics.
Surgical Procedures Outlook
Under surgical procedures type, the market is categorized into breast augmentation, facelift & body lift, rhinoplasty, and others. In 2022, the breast augmentation segment registered the maximum revenue share in the market. Breast augmentation is one of the most popular surgical procedures in the medical aesthetics market. Many individuals seek breast augmentation to enhance the size and shape of their breasts, improving overall body proportions and boosting self-confidence. Women of various ages and backgrounds consider breast augmentation, and it's a procedure that appeals to a broad range of patients.
Product Outlook
By product, the market is categorized into facial aesthetic products, cosmetics implant, skin aesthetic devices, body contouring devices, physician-dispensed cosmeceuticals & skin lighteners, hair removal devices, tattoo removal devices, and others. The cosmetics implant segment covered a considerable revenue share in the market in 2022. Cosmetic implants have been a longstanding and important component of the medical aesthetics market. They are used to enhance and reshape various facial features and body contours, and they can provide long-lasting results. One of the most well-known cosmetic surgery operations is the enlargement of the breasts with silicone or saline breast implants.
Regional Outlook
Region-wise, the medical aesthetics market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the medical aesthetics market by generating the highest revenue share. Non-surgical treatments are particularly popular in North America. Common procedures include Botox and dermal filler injections, laser therapy, chemical peels, and microdermabrasion. The aging population in North America has contributed to expanding the medical aesthetics market as individuals seek treatments to address signs of aging and maintain a youthful appearance.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC (AbbVie, Inc.), Alma Lasers Ltd. (Sisram Medical Ltd.), Bausch Health Companies Inc, Anika Therapeutics, Inc, Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Candela corporation, Lumenis Be Ltd., Galderma S.A., and Cutera, Inc.
Recent Strategies Deployed in Medical Aesthetics Market
Acquisition and Mergers:
Jul-2023: Alma Lasers Ltd. a subsidiary of Sisram Medical Ltd. acquired PhotonMed, a medical device company focused on developing and commercializing innovative laser-based technologies for various medical and aesthetic applications. Through this acquisition, PhotonMed would signify a major step in Sisram's strategy to directly engage with consumers, strengthening its market position and brand recognition, as the company shifts from a distribution model to a direct presence, enhancing its industry leadership.
Dec-2022: Johnson & Johnson acquired Abiomed, a leading medical device company specializing in developing and manufacturing advanced heart recovery and support technologies. Through this acquisition, Johnson & Johnson would be able to broaden its offerings in the rapidly growing cardiovascular sector by incorporating heart recovery solutions into our globally leading Biosense Webster electrophysiology business.
Jan-2022: Galderma S.A. took over ALASTIN Skincare, a company specializing in providing innovative, clinically proven skincare products and regimens that support and enhance the skin's natural regenerative processes. Through this acquisition, both companies would develop products that complement our high-quality product lineup.
Dec-2021: Allergan PLC took over Soliton, Inc., a medical technology company specializing in developing and commercializing innovative solutions for tattoo removal and cellulite treatment. Through this acquisition, the technology and experience of Solution, Inc. would enhance Allergan Aesthetics' range of non-invasive body sculpting solutions by introducing a proven method for addressing the appearance of cellulite.
Sep-2021: Galderma S.A. acquired Sofregen Medical, Inc, a biotechnology company dedicated to developing innovative medical solutions, with a particular focus on advancing regenerative medicine and bioengineering applications. Through this acquisition, Sofregen Medical would help Galderma in expanding its capabilities.
Sep-2020: Bausch Health Companies Inc. a subsidiary of Bausch + Lomb took over Allegro Ophthalmics, a biopharmaceutical company focused on the research and development of novel treatments for retinal diseases and eye conditions. Through this acquisition, the ophthalmic assets of Allegro would be added to the product portfolio of Bausch Health.
Apr-2019: Merz Pharma GmbH and Co. KGaA acquired Mederma, a brand in the skincare industry, recognized for its scar and stretch mark treatment products. Through this acquisition, Merz Pharma established a robust consumer healthcare foundation in the United States and aims to advance its progress through ambitious organic expansion, introducing innovative Rx to OTC switches.
Partnerships, Collaborations, and Agreements:
Sep-2021: Lumenis Be Ltd. Came into partnership with Laseraid, a leading provider of laser equipment and support services for the medical and aesthetic industries. Through this partnership, more clinics would have the opportunity to utilize Lumenis' distinctive Splendor X technology, featuring its exclusive integrated plume evacuator and HEPA filter, enhancing safety for both operators and patients.
Jan-2020: Candela Corporation came into partnership with MT.DERM GmbH, is a company specializing in the development and manufacturing of innovative medical devices, particularly in the field of micro-needling and tattoo removal technology. Through this partnership, the Exceed medical micro needling system bolsters Candela's product lineup, reinforcing its commitment to delivering customers a comprehensive range of leading-edge medical aesthetic technologies.
Product Launches:
Sep-2023: Cutera, Inc. introduced Secret DUO, a groundbreaking skin revitalization and resurfacing system that combines two non-ablative fractional technologies, offering the flexibility to use each method independently or in tandem to address a broad spectrum of aesthetic concerns.
Mar-2023: Galderma S.A. launched FACE, an education and training initiative offered by Galderma, focusing on the art and science of facial aesthetics, aimed at empowering healthcare professionals with the expertise and proficiency required to deliver high-quality facial aesthetic treatments.
Feb-2022: Merz Pharma GmbH and Co. KGaA launched Radiesse, a dermal filler known for its ability to restore volume, reduce wrinkles, and stimulate collagen production for long-lasting facial rejuvenation. With the launch of Radiesse, Merz Pharma would provide their clients and patients with a safe, effective, and non-invasive solution for addressing the loss of jawline contour with this approval.
Market Segments covered in the Report:
By End User
By Procedure
By Product
By Geography
Companies Profiled
Unique Offerings from KBV Research